Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-053657
Filing Date
2021-08-27
Accepted
2021-08-27 17:08:22
Documents
2
Period of Report
2021-08-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3989
2 POA DOCUMENT poa.txt EX-24.4_1006051 3047
  Complete submission text file 0001209191-21-053657.txt   8378
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 614 DAVIS STREET EVANSTON IL 60201
Business Address
Corning Luke (Reporting) CIK: 0001836654 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 211220009